Tumor response following neoadjuvant MR-guided single ablative dose partial breast irradiation.

[1]  F. Alongi,et al.  Preoperative radiotherapy: A paradigm shift in the treatment of breast cancer? A review of literature. , 2019, Critical reviews in oncology/hematology.

[2]  B. Yaremko,et al.  Stereotactic image-guided neoadjuvant ablative single-dose radiation, then lumpectomy, for early breast cancer: the SIGNAL prospective single-arm trial of single-dose radiation therapy. , 2019, Current oncology.

[3]  J. Yarnold,et al.  Patient-Reported Outcomes Over 5 Years After Whole- or Partial-Breast Radiotherapy: Longitudinal Analysis of the IMPORT LOW (CRUK/06/003) Phase III Randomized Controlled Trial , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  A. Rosso,et al.  One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study. , 2018, The Lancet. Oncology.

[5]  E. Mamounas.  Omitting Surgery in Complete Responders After Neoadjuvant Chemotherapy: The Quest Continues , 2018, Annals of Surgical Oncology.

[6]  W. Uter,et al.  Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trial. , 2018, The Lancet. Oncology.

[7]  M. J. van de Vijver,et al.  Response to preoperative radiotherapy in relation to gene expression patterns in breast cancer patients. , 2017, International journal of radiation oncology, biology, physics.

[8]  I. Ellis,et al.  Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial , 2017, The Lancet.

[9]  S. Yoo,et al.  Treatment constraints for single dose external beam preoperative partial breast irradiation in early-stage breast cancer , 2017, Clinical and translational radiation oncology.

[10]  L. Boersma,et al.  Preoperative breast radiation therapy: Indications and perspectives. , 2017, European journal of cancer.

[11]  H. Kuerer,et al.  Nonoperative Management for Invasive Breast Cancer After Neoadjuvant Systemic Therapy: Conceptual Basis and Fundamental International Feasibility Clinical Trials , 2017, Annals of Surgical Oncology.

[12]  A. Francken,et al.  Towards omitting breast cancer surgery in select patient groups: Assessment of pathologic complete response after neoadjuvant systemic therapy using biopsies—The MICRA trial. , 2017 .

[13]  Tanya W. Moseley,et al.  A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy , 2017, Annals of surgery.

[14]  R. Arriagada,et al.  Preoperative radiotherapy in breast cancer patients: 32 years of follow-up. , 2017, European journal of cancer.

[15]  S. Feigenberg,et al.  Preoperative Accelerated Partial Breast Irradiation for Early-Stage Breast Cancer: Preliminary Results of a Prospective, Phase 2 Trial. , 2017, International journal of radiation oncology, biology, physics.

[16]  P. V. van Diest,et al.  Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol , 2017, BMC Cancer.

[17]  Alphonse G. Taghian,et al.  Accelerated Partial Breast Irradiation: Executive summary for the update of an ASTRO Evidence-Based Consensus Statement. , 2017, Practical radiation oncology.

[18]  R. Pötter,et al.  Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial , 2017, The Lancet. Oncology.

[19]  A. Bardia,et al.  Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis. , 2016, JAMA oncology.

[20]  F. Yin,et al.  Assessment of Treatment Response With Diffusion-Weighted MRI and Dynamic Contrast-Enhanced MRI in Patients With Early-Stage Breast Cancer Treated With Single-Dose Preoperative Radiotherapy , 2016, Technology in cancer research & treatment.

[21]  H. Kuerer,et al.  Selective elimination of breast cancer surgery in exceptional responders: historical perspective and current trials , 2016, Breast Cancer Research.

[22]  Ahmedin Jemal,et al.  Global Cancer Incidence and Mortality Rates and Trends—An Update , 2015, Cancer Epidemiology, Biomarkers & Prevention.

[23]  M. Dewhirst,et al.  Preoperative Single-Fraction Partial Breast Radiation Therapy: A Novel Phase 1, Dose-Escalation Protocol With Radiation Response Biomarkers. , 2015, International journal of radiation oncology, biology, physics.

[24]  D. Roder,et al.  Breast cancer survival in New Zealand women , 2015, ANZ journal of surgery.

[25]  Nico Karssemeijer,et al.  MR Imaging as an Additional Screening Modality for the Detection of Breast Cancer in Women Aged 50-75 Years with Extremely Dense Breasts: The DENSE Trial Study Design. , 2015, Radiology.

[26]  Harry Bartelink,et al.  First results of the preoperative accelerated partial breast irradiation (PAPBI) trial. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[27]  J. Kenkre,et al.  The incidence and 10-year survival of interval breast cancers in Wales. , 2014, Clinical radiology.

[28]  A. Luini,et al.  Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial. , 2013, The Lancet. Oncology.

[29]  T. Major,et al.  Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  Les Irwig,et al.  Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy. , 2013, Journal of the National Cancer Institute.

[31]  C. Coles,et al.  Association of breast tumour bed seroma with post-operative complications and late normal tissue toxicity: results from the Cambridge Breast IMRT trial. , 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[32]  E. Yorke,et al.  Use of normal tissue complication probability models in the clinic. , 2010, International journal of radiation oncology, biology, physics.

[33]  R. Pötter,et al.  Patient selection for accelerated partial-breast irradiation (APBI) after breast-conserving surgery: recommendations of the Groupe Européen de Curiethérapie-European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) breast cancer working group based on clinical evidence (2009). , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[34]  Uulke A. van der Heide,et al.  Simultaneous multi-modality ROI delineation in clinical practice , 2009, Comput. Methods Programs Biomed..

[35]  David J Brenner,et al.  The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. , 2008, Seminars in radiation oncology.

[36]  Les Irwig,et al.  Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  Jaime S. Cardoso,et al.  Towards an intelligent medical system for the aesthetic evaluation of breast cancer conservative treatment , 2007, Artif. Intell. Medicine.

[38]  C. Coles,et al.  Reduction of radiotherapy-induced late complications in early breast cancer: the role of intensity-modulated radiation therapy and partial breast irradiation. Part II--Radiotherapy strategies to reduce radiation-induced late effects. , 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

[39]  C. Coles,et al.  Reduction of radiotherapy-induced late complications in early breast cancer: the role of intensity-modulated radiation therapy and partial breast irradiation. Part I--normal tissue complications. , 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

[40]  C. Kuhl,et al.  Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? , 1999, Radiology.

[41]  N. Aaronson,et al.  The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[43]  J R Yarnold,et al.  Cosmetic and functional outcomes of breast conserving treatment for early stage breast cancer. 1. Comparison of patients' ratings, observers' ratings, and objective assessments. , 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[44]  R. Arriagada,et al.  Radiotherapy alone in breast cancer. I. Analysis of tumor parameters, tumor dose and local control: the experience of the Gustave-Roussy Institute and the Princess Margaret Hospital. , 1985, International journal of radiation oncology, biology, physics.

[45]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[46]  H. Verkooijen,et al.  Severe depression more common in patients with ductal carcinoma in situ than early-stage invasive breast cancer patients , 2017, Breast Cancer Research and Treatment.

[47]  J. Coebergh,et al.  Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - a population based study from the Netherlands. , 2014, European journal of cancer.

[48]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.